Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy-Reference-Cited by-同舟云学术

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy

Published:2020-08 Issue: Volume:58 Page:102899
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Christakoudi Sofia^ORCID,Runglall Manohursingh,Mobillo Paula,Rebollo-Mesa Irene,Tsui Tjir-Li,Nova-Lamperti Estefania,Taube Catharine,Norris Sonia,Kamra Yogesh,Hilton Rachel,Augustine Titus,Bhandari Sunil,Baker Richard,Berglund David,Carr Sue,Game David,Griffin Sian,Kalra Philip A.,Lewis Robert,Mark Patrick B.,Marks Stephen D.,MacPhee Iain,McKane William,Mohaupt Markus G.,Paz-Artal Estela,Kon Sui Phin,Serón Daniel,Sinha Manish D.,Tucker Beatriz,Viklický Ondrej,Stahl Daniel,Lechler Robert I.,Lord Graham M.,Hernandez-Fuentes Maria P.

Funder

Guy's and St Thomas' Charity

Seventh Framework Programme

Medical Research Council

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients;Massart;Nephrol Dial Transplant,2016

2. Immunosuppression withdrawal following liver transplantation;Whitehouse;Clin Res Hepatol Gastroenterol,2014

3. Operational tolerance in kidney transplantation and associated biomarkers;Massart;Clin Exp Immunol,2017